Epilepsy Drugs Market Report and Global Forecast 2024-2030, Featuring Eisai, UCB, H. Lundbeck, GW Pharmaceuticals, Abbott, Alkem Laboratories, Bausch Health Companies, GSK, Novartis and Pfizer Dublin, May 06, 2024 (GLOBE NEWSWIRE) -- The "Epilepsy Drugs Market, Size, Global Forecast 2024-2030, Industry Trends, Share, Growth, Insight, Impact of Inflation, Top Companies Analysis" report has...

Epilepsy Market Insight, Epidemiology and Market Forecast to 2032 Dublin, Jan. 25, 2024 (GLOBE NEWSWIRE) -- The "Epilepsy - Market Insight, Epidemiology and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. Recent research on...

Epilepsy Treatment Market Anticipates Reaching a Valuation of $14.7 Billion by 2033, Propelled by a Robust CAGR of 7.7%, according to projections by Persistence Market Research New York, Jan. 11, 2024 (GLOBE NEWSWIRE) -- The global epilepsy treatment market revolves around the management and treatment of epilepsy, a neurological disorder characterized by recurrent...

United States Epilepsy Market Analysis and Competitive Landscape Report 2022 Dublin, Feb. 02, 2023 (GLOBE NEWSWIRE) -- The "US Epilepsy Market and Competitive Landscape - 2022" report has been added to ResearchAndMarkets.com's offering.The report provides comprehensive...

Epilepsy - Worldwide Market and Epidemiology Insights & Forecasts to 2030 Dublin, Jan. 22, 2021 (GLOBE NEWSWIRE) -- The "Epilepsy - Market Insight, Epidemiology and Market Forecast - 2030" drug pipelines has been added to ResearchAndMarkets.com's offering. This report...